221 related articles for article (PubMed ID: 12577148)
41. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
Thatrimontrichai A; Apisarnthanarak A; Chanvitan P; Janjindamai W; Dissaneevate S; Maneenil G
Pediatr Infect Dis J; 2013 Feb; 32(2):140-5. PubMed ID: 22935872
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
[TBL] [Abstract][Full Text] [Related]
43. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study.
Soufir L; Timsit JF; Mahe C; Carlet J; Regnier B; Chevret S
Infect Control Hosp Epidemiol; 1999 Jun; 20(6):396-401. PubMed ID: 10395140
[TBL] [Abstract][Full Text] [Related]
44. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.
Cisneros JM; Reyes MJ; Pachón J; Becerril B; Caballero FJ; García-Garmendía JL; Ortiz C; Cobacho AR
Clin Infect Dis; 1996 Jun; 22(6):1026-32. PubMed ID: 8783704
[TBL] [Abstract][Full Text] [Related]
45. Predictors of mortality in surgical patients with Acinetobacter baumannii bacteremia.
Chen SJ; Chao TF; Chiang MC; Kuo SC; Chen LY; Chiang DH; Yin T; Chen TL; Fung CP
J Microbiol Immunol Infect; 2011 Jun; 44(3):209-14. PubMed ID: 21524616
[TBL] [Abstract][Full Text] [Related]
46. Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification.
Chiang DH; Wang CC; Kuo HY; Chen HP; Chen TL; Wang FD; Cho WL; Liu CY
J Microbiol Immunol Infect; 2008 Oct; 41(5):397-402. PubMed ID: 19122921
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.
Weingarten CM; Rybak MJ; Jahns BE; Stevenson JG; Brown WJ; Levine DP
Pharmacotherapy; 1999 Sep; 19(9):1080-5. PubMed ID: 10610015
[TBL] [Abstract][Full Text] [Related]
48. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine.
Al Jarousha AM; El Jadba AH; Al Afifi AS; El Qouqa IA
Int J Infect Dis; 2009 Sep; 13(5):623-8. PubMed ID: 19144555
[TBL] [Abstract][Full Text] [Related]
49. Blood stream infections caused by Acinetobacter baumannii group in Japan - Epidemiological and clinical investigation.
Fujikura Y; Yuki A; Hamamoto T; Kawana A; Ohkusu K; Matsumoto T
J Infect Chemother; 2016 Jun; 22(6):366-71. PubMed ID: 26993173
[TBL] [Abstract][Full Text] [Related]
50. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.
García-Garmendia JL; Ortiz-Leyba C; Garnacho-Montero J; Jiménez-Jiménez FJ; Monterrubio-Villar J; Gili-Miner M
Crit Care Med; 1999 Sep; 27(9):1794-9. PubMed ID: 10507600
[TBL] [Abstract][Full Text] [Related]
51. Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis.
Zhou HY; Yuan Z; Du YP
Int J Infect Dis; 2014 May; 22():25-30. PubMed ID: 24607429
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of risk factors on prognosis of Acinetobacter baumannii bloodstream infection].
Qiao L; Zhang JS; Mei YN; Zhang HZ; Su CL
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):471-4. PubMed ID: 24021042
[TBL] [Abstract][Full Text] [Related]
53. Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy.
Villari P; Iacuzio L; Vozzella EA; Bosco U
Am J Infect Control; 1999 Jun; 27(3):247-53. PubMed ID: 10358227
[TBL] [Abstract][Full Text] [Related]
54. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.
Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M
J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770
[TBL] [Abstract][Full Text] [Related]
55. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
Blot SI; Depuydt P; Annemans L; Benoit D; Hoste E; De Waele JJ; Decruyenaere J; Vogelaers D; Colardyn F; Vandewoude KH
Clin Infect Dis; 2005 Dec; 41(11):1591-8. PubMed ID: 16267731
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia.
Kuo SC; Lee YT; Yang SP; Chiang MC; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):634-9. PubMed ID: 22776466
[TBL] [Abstract][Full Text] [Related]
57. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
[TBL] [Abstract][Full Text] [Related]
58. Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality.
Garrouste-Orgeas M; Marie O; Rouveau M; Villiers S; Arlet G; Schlemmer B
J Hosp Infect; 1996 Dec; 34(4):279-89. PubMed ID: 8971617
[TBL] [Abstract][Full Text] [Related]
59. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
60. Mortality from
John AO; Paul H; Vijayakumar S; Anandan S; Sudarsan T; Abraham OC; Balaji V
Indian J Med Microbiol; 2020; 38(1):24-31. PubMed ID: 32719205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
